Nitric oxide synthase inhibition in migraine

Lancet

Volumn 349, Issue 9049, 1997, Pages 401-402

  Lassen, L H ^a   Ashina, M ^b   Christiansen, I ^b   Ulrich, V ^b   Olesen, J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME INHIBITION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; NAUSEA; PHOTOPHOBIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031046983     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80021-9     Document Type: Article

References (5)

1. Thomsen LL, Kruuse C, Iversen HK, Olesen J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1994; 1: 73-80.
2. Lassen LH, Thomsen LL, Olesen J. Histamine induces migraine via the H1-receptor: support for the NO hypothesis of migraine. Neuroreport 1995; 6: 1475-79.
3. Olesen J, Thomsen LL, Lasssen LH, Olesen IJ. The nitic oxide hypothesis of migraine and other vascular headaches. Cephalalgia 1995; 15: 94-100.
4. Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 19-28.
5. Thomsen LL, Iversen HK, Olesen J. Increased cerebrovascular pCO2 reactivity in migraine with aura: transcranial Doppler study during hyperventilation. Cephalalgia 1995; 15: 211-15.